HER2 Status in Ovarian Carcinomas: A Multicenter GINECO Study of 320 Patients

BACKGROUND: Despite a typically good response to first-line combination chemotherapy, the prognosis for patients with advanced ovarian cancer remains poor because of acquired chemoresistance. The use of targeted therapies such as trastuzumab may potentially improve outcomes for patients with ovarian...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Tuefferd, Marianne, Couturier, Jérôme, Penault-Llorca, Frédérique, Vincent-Salomon, Anne, Broët, Philippe, Guastalla, Jean-Paul, Allouache, Djelila, Combe, Martin, Weber, Béatrice, Pujade-Lauraine, Eric, Camilleri-Broët, Sophie
Materialtyp: Artigo
Språk:Inglês
Publicerad: Public Library of Science 2007
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2042515/
https://ncbi.nlm.nih.gov/pubmed/17987122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0001138
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk